Invention Grant
- Patent Title: Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
- Patent Title (中): 胸腺抑素的药学上可接受的盐及其制造方法
-
Application No.: US13424343Application Date: 2012-03-19
-
Publication No.: US08735602B2Publication Date: 2014-05-27
- Inventor: Tim Fat Tam , Blaise N'Zemba , Regis Leung-Toung , Yingsheng Wang , Yanqing Zhao , Lily Yu
- Applicant: Tim Fat Tam , Blaise N'Zemba , Regis Leung-Toung , Yingsheng Wang , Yanqing Zhao , Lily Yu
- Applicant Address: CA Toronto, ON
- Assignee: Apotex Technologies inc.
- Current Assignee: Apotex Technologies inc.
- Current Assignee Address: CA Toronto, ON
- Agency: Sim & McBurey
- Priority: CA2571645 20061219
- Main IPC: C07D209/12
- IPC: C07D209/12
Abstract:
The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan potassium salt (1:1), D-isoglutamyl-D-tryptophan lithium salt (1:1), D-isoglutamyl-D-tryptophan calcium salt (2:1), D-isoglutamyl-D-tryptophan magnesium salt (2:1), and D-isoglutamyl-D-tryptophan organic ammonium salts (1:1).
Public/Granted literature
- US20130072692A1 PHARMACEUTICALLY ACCEPTABLE SALTS OF THYMODEPRESSIN AND PREOCESSES FOR THEIR MANUFACTURE. Public/Granted day:2013-03-21
Information query
